{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:16:35Z","timestamp":1790507795723,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003050","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI","doi-asserted-by":"publisher","award":["25461730"],"award-info":[{"award-number":["25461730"]}],"id":[{"id":"10.13039\/501100003050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003050","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI","doi-asserted-by":"publisher","award":["22390225"],"award-info":[{"award-number":["22390225"]}],"id":[{"id":"10.13039\/501100003050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003050","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI","doi-asserted-by":"publisher","award":["23659565"],"award-info":[{"award-number":["23659565"]}],"id":[{"id":"10.13039\/501100003050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003050","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI","doi-asserted-by":"publisher","award":["221S0003"],"award-info":[{"award-number":["221S0003"]}],"id":[{"id":"10.13039\/501100003050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Foundation for Neuroscience and Mental Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.neulet.2014.08.052","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T07:15:21Z","timestamp":1410333321000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment"],"prefix":"10.1016","volume":"582","author":[{"given":"Hidenaga","family":"Yamamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Umeda-Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.08.052_bib0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-1781(91)90062-T","article-title":"Plasma serine in schizophrenics and controls measured by gas chromatography\u2013mass spectrometry","volume":"37","author":"Baruah","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","article-title":"A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia","volume":"90","author":"Bendikov","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.neubiorev.2013.06.007","article-title":"NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case\u2013control studies","volume":"37","author":"Brouwer","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2014.08.052_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2012.09.014","article-title":"Plasma levels of d-serine in Brazilian individuals with schizophrenia","volume":"142","author":"Calcia","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D'Souza","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4306\/pi.2008.5.4.203","article-title":"Peripheral amino acid levels in schizophrenia and antipsychotic treatment","volume":"5","author":"De Luca","year":"2008","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neulet.2014.08.052_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archpsyc.56.1.13","article-title":"Glycine agonists: what can they teach us about schizophrenia?","volume":"56","author":"Farber","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(94)90043-4","article-title":"Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis","volume":"51","author":"Fekkes","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/bmc.394","article-title":"Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection","volume":"18","author":"Fukushima","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.neulet.2014.08.052_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(92)80397-Y","article-title":"The presence of free d-serine in rat brain","volume":"296","author":"Hashimoto","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neulet.2014.08.052_bib0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0065","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpsychires.2012.03.015","article-title":"Different serine and glycine metabolism in patients with schizophrenia receiving clozapine","volume":"46","author":"Hons","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psychres.2009.11.008","article-title":"Glycine serum level in schizophrenia: relation to negative symptoms","volume":"176","author":"Hons","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2014.08.052_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1781(87)90108-9","article-title":"Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients","volume":"22","author":"Korpi","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(90)90136-S","article-title":"Amino acid patterns in schizophrenia: some new findings","volume":"32","author":"Macciardi","year":"1990","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2014.08.052_bib0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1471-4159.1995.65010454.x","article-title":"Functional comparison of d-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration","volume":"65","author":"Matsui","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.08.052_bib0100","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2010.08.027","article-title":"Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia","volume":"35","author":"Ohnuma","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0110","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.pnpbp.2008.07.022","article-title":"Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP)","volume":"32","author":"Ohnuma","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(82)90212-9","article-title":"Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction","volume":"28","author":"Perry","year":"1982","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2014.08.052_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2014.08.052_bib0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.biopsych.2005.03.018","article-title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels","volume":"57","author":"Yamada","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2014.08.052_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2013.09.059","article-title":"Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine","volume":"556","author":"Yamamori","year":"2013","journal-title":"Neurosci. Lett."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014007356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014007356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:17:31Z","timestamp":1759609051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014007356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"alternative-id":["S0304394014007356"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.08.052","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}